Vasoactive intestinal peptide inhibits IL-8 production in human monocytes by downregulating nuclear factor κB-dependent transcriptional activity
- 7 March 2003
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 302 (2) , 275-283
- https://doi.org/10.1016/s0006-291x(03)00149-9
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Immunobiology of vasoactive intestinal peptide (VIP)Immunology Today, 2000
- Phosphorylation of NF-κB p65 by PKA Stimulates Transcriptional Activity by Promoting a Novel Bivalent Interaction with the Coactivator CBP/p300Molecular Cell, 1998
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- The Transcriptional Activity of NF-κB Is Regulated by the IκB-Associated PKAc Subunit through a Cyclic AMP–Independent MechanismCell, 1997
- Human Chemokines: An UpdateAnnual Review of Immunology, 1997
- Inhibition of Tumor Necrosis Factor-Alpha and lnterleukin-1-Beta Production by Beta-Adrenoceptor Agonists from Lipopolysaccharide- Stimulated Human Peripheral Blood Mononuclear CellsPharmacology, 1997
- Transcriptional control: Versatile molecular glueCurrent Biology, 1996
- A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear ReceptorsCell, 1996
- Establishment of Lipopolysaccharide-dependent Nuclear Factor κB Activation in a Cell-free SystemPublished by Elsevier ,1995
- Interaction of vasoactive intestinal peptide with human blood mononuclear cellsMolecular and Cellular Endocrinology, 1981